Merck & Co Inc reports results for the quarter ended in September 30 - Earnings Summary

Reuters11-01

* Merck & Co Inc reported quarterly adjusted earnings of $1.57​​ per share for the quarter ended September 30, lower than the same quarter last year, when the company reported EPS of $2.13. The mean expectation of eighteen analysts for the quarter was for earnings of $1.50 per share. Wall Street expected results to range from $1.33 to $1.85 per share.

* Revenue rose 4.4% to $16.66 billion from a year ago; analysts expected $16.46 billion.

* Merck & Co Inc's reported EPS for the quarter was $1.24​.

* The company reported quarterly net income of $3.16 billion.

* Merck & Co Inc shares had fallen by 7.7% this quarter and lost 3.8% so far this year.

FORECAST CHANGES

* The mean earnings estimate of analysts had fallen by about 16.1% in the last three months.​

* In the last 30 days, fourteen analysts negatively revised earnings estimates

RECOMMENDATIONS

* The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 24 "strong buy" or "buy," 5 "hold" and no "sell" or "strong sell."

* The average consensus recommendation for the pharmaceuticals peer group is also "buy"

Wall Street's median 12-month price target for Merck & Co Inc is $136.00 This summary was machine generated from LSEG data November 1 at 03:07 a.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,

MISSED

Sep. 30 2024 1.50 1.57 Beat

Jun. 30 2024 2.15 2.28 Beat

Mar. 31 2024 1.88 2.07 Beat

Dec. 31 2023 -0.11 0.03 Beat

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

Leave a comment
1
1